MarginsXMarginsX
Home › Markets › Health Care › CRBP

Corbus Pharmaceuticals Holdings Inc. (CRBP)

CRBP trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.38
-0.44% on the day
Market cap
$69.5M
Micro cap
Revenue · 2022
$0
-100.0% on 2021
Net income · 2022
-$42.3M

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2022-12-31, https://www.sec.gov/Archives/edgar/data/1595097/000095017023006469/0000950170-23-006469-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2022-12-31.

Profile

FieldValue
TickerCRBP on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001595097
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2022

LineValue
Revenue$0
Net income-$42.3M
Operating income-$39.8M
Net marginNeeds revenue and net income
Operating marginOperating income not reported
Revenue growth-100.0%
Cash$17.0M
Total assets$66.3M
P/E (computed)Net income was not positive
P/S (computed)Needs market cap and revenue

Warning signs

Cash runway
3.9 months
$30.2M cash at September 30, 2026
Share count, 1 year
+17.4%
2025-11-07 to 2026-11-06 · +365.8% over 3 years
Going-concern doubt
No
10-Q filed November 10, 2026
Insider net buying, 12 months
-$1.6M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-10
Cash and burn$30.2M cash; operating cash flow -$23.1M a quarter.Report 2026-09-30
Shares outstanding20,606,760 (2026-11-06); 17,553,037 a year earlier; 4,423,683 three years earlier.Cover page 2026-11-06
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-08-07
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorEisnerAmper LLP, Iselin, New Jersey, United StatesPCAOB Form AP 2026-03-09
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $126K, sold $1.7M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$37.8M-$21.2M$30.2MNo debt tagsNeeds four quarters10-Q 2026-11-10
Q2 2026
2026-06-30
Not filed-$35.0M-$29.6M$23.4MNo debt tagsNeeds four quarters10-Q 2026-08-06
Q1 2026
2026-03-31
Not filed-$23.0M-$25.6M$25.7MNo debt tagsNeeds four quarters10-Q 2026-05-12
Q4 2025
2025-12-31
Not filed-$20.6M-$15.9M$28.5MNo debt tagsNeeds four quarters10-K 2026-03-09
Q3 2025
2025-09-30
Not filed-$23.3M-$15.6M$27.0MNo debt tagsNeeds four quarters10-Q 2026-11-10
Q2 2025
2025-06-30
Not filed-$17.7M-$16.6M$20.0MNo debt tagsNeeds four quarters10-Q 2026-08-06
Q1 2025
2025-03-31
Not filed-$17.0M-$16.4M$18.9MNo debt tagsNeeds four quarters10-Q 2026-05-12
Q4 2024
2024-12-31
Not filed-$9.5M-$10.9M$17.2M$0Needs four quarters10-K 2026-03-09

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-08-07
Latest annual report10-K2026-03-09
Latest quarterly / interim10-Q2026-11-10
Latest current report8-K2026-11-16
Latest proxyDEFA14A2026-04-16

Source: SEC EDGAR submissions feed, 812 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+10.4%
1 month-29.1%
3 months-66.4%
Year to date-58.4%
1 year-69.4%
From 52-week high-72.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
COYACoya Therapeutics Inc.$3.00-4.15%$70.4M
MNOVMedicinova Inc$1.34-3.94%$68.7M
VTVTvTv Therapeutics Inc.$17.69-10.16%$71.0M
ZYBTZhengye Biotechnology Holding Limited$1.43-4.67%$67.8M
TENXTenax Therapeutics Inc.$1.48-8.64%$67.4M
GOSSGossamer Bio Inc.$10.98+0.09%$67.2M
TLSATiziana Life Sciences Ltd. Common Shares$0.5762+1.11%$73.3M
KALAKALA BIO Inc.$3.83-8.02%$74.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier